A New Type of Drug Ad

I‘m not going to say much about it since I’m involved in other Cox-2 litigation, but coverage of the new Pfizer ads for Celebrex certainly are interesting, as is the ad itself.  The ads are 150 seconds long, with the risk fair balance content first and rather specific, expressly referencing death as a potential side effect of any NSAID.